Effects of the Apolipoprotein E ε4 Allele on Functional MRI during n-Back Working Memory Tasks in Healthy Middle-Aged Adults

REFERENCES

1. 1.↵
   1. van Duijn CM,
   2. Clayton D,
   3. Chandra V,
   4. et al

   . Familial aggregation of Alzheimer's disease and related disorders: a collaborative re-analysis of case-control studies. Int J Epidemiol 1991;20(suppl 2):S13–20

   PubMedWeb of Science
2. 2.↵
   1. Waring SC,
   2. Rosenberg RN

   . Genome-wide association studies in Alzheimer disease. Arch Neurol 2008;65:329–34

   CrossRefPubMed
3. 3.↵
   1. Strittmatter WJ,
   2. Saunders AM,
   3. Schmechel D,
   4. et al

   . Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A 1993;90:1977–81

   Abstract/FREE Full Text
4. 4.↵
   1. Small GW

   . Neuroimaging and genetic assessment for early diagnosis of Alzheimer's disease. J Clin Psychiatry 1996;57(suppl 14):9–13
5. 5.↵
   1. Chen K,
   2. Reiman EM,
   3. Alexander GE,
   4. et al

   . Correlations between apolipoprotein E epsilon4 gene dose and whole brain atrophy rates. Am J Psychiatry 2007;164:916–21

   CrossRefPubMedWeb of Science
6. 6.↵
   1. Caselli RJ,
   2. Graff-Radford NR,
   3. Reiman EM,
   4. et al

   . Preclinical memory decline in cognitively normal apolipoprotein E-epsilon4 homozygotes. Neurology 1999;53:201–07

   CrossRef
7. 7.↵
   1. Pievani M,
   2. Galluzzi S,
   3. Thompson PM,
   4. et al

   . APOE4 is associated with greater atrophy of the hippocampal formation in Alzheimer's disease. Neuroimage 2011;55:909–19

   CrossRefPubMed
8. 8.↵
   1. Donix M,
   2. Burggren AC,
   3. Suthana NA,
   4. et al

   . Longitudinal changes in medial temporal cortical thickness in normal subjects with the APOE-4 polymorphism. Neuroimage 2010;53:37–43

   CrossRefPubMed
9. 9.↵
   1. Reiman EM,
   2. Chen K,
   3. Alexander GE,
   4. et al

   . Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism. Proc Natl Acad Sci U S A 2005;102:8299–302

   Abstract/FREE Full Text
10. 10.↵
    1. Ogawa S,
    2. Lee TM,
    3. Nayak AS,
    4. et al

    . Oxygenation-sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields. Magn Reson Med 1990;14:68–78

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Ogawa S,
    2. Lee TM,
    3. Kay AR,
    4. et al

    . Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc Natl Acad Sci U S A 1990;87:9868–72

    Abstract/FREE Full Text
12. 12.↵
    1. Logothetis NK,
    2. Pauls J,
    3. Augath M,
    4. et al

    . Neurophysiological investigation of the basis of the fMRI signal. Nature 2001;412:150–57

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Ogawa S,
    2. Lee TM,
    3. Stepnoski R,
    4. et al

    . An approach to probe some neural systems interaction by functional MRI at neural time scale down to milliseconds. Proc Natl Acad Sci U S A 2000;97:11026–31

    Abstract/FREE Full Text
14. 14.↵
    1. Rees G,
    2. Friston K,
    3. Koch C

    . A direct quantitative relationship between the functional properties of human and macaque V5. Nat Neurosci 2000;3:716–23

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Baddeley A

    . Working memory. Science 1992;255:556–59

    Abstract/FREE Full Text
16. 16.↵
    1. Bledowski C,
    2. Kaiser J,
    3. Rahm B

    . Basic operations in working memory: contributions from functional imaging studies. Behav Brain Res 2010;214:172–79

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Dubois B,
    2. Feldman HH,
    3. Jacova C,
    4. et al

    . Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007;6:734–46

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Rosen VM,
    2. Bergeson JL,
    3. Putnam K,
    4. et al

    . Working memory and apolipoprotein E: what's the connection? Neuropsychologia 2002;40:2226–33

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Belleville S,
    2. Chertkow H,
    3. Gauthier S

    . Working memory and control of attention in persons with Alzheimer's disease and mild cognitive impairment. Neuropsychology 2007;21:458–69

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Belleville S,
    2. Sylvain-Roy S,
    3. de Boysson C,
    4. et al

    . Characterizing the memory changes in persons with mild cognitive impairment. Prog Brain Res 2008;169:365–75

    CrossRefPubMedWeb of Science
21. 21.↵
    1. D'Esposito M,
    2. Postle BR,
    3. Jonides J,
    4. et al

    . The neural substrate and temporal dynamics of interference effects in working memory as revealed by event-related functional MRI. Proc Natl Acad Sci U S A 1999;96:7514–19

    Abstract/FREE Full Text
22. 22.↵
    1. Rypma B,
    2. D'Esposito M

    . Isolating the neural mechanisms of age-related changes in human working memory. Nat Neurosci 2000;3:509–15

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Ranganath C,
    2. Johnson MK,
    3. D'Esposito M

    . Prefrontal activity associated with working memory and episodic long-term memory. Neuropsychologia 2003;41:378–89

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Narayanan NS,
    2. Prabhakaran V,
    3. Bunge SA,
    4. et al

    . The role of the prefrontal cortex in the maintenance of verbal working memory: an event-related FMRI analysis. Neuropsychology 2005;19:223–32

    CrossRefPubMedWeb of Science
25. 25.↵
    1. Crone EA,
    2. Wendelken C,
    3. Donohue S,
    4. et al

    . Neurocognitive development of the ability to manipulate information in working memory. Proc Natl Acad Sci U S A 2006;103:9315–20

    Abstract/FREE Full Text
26. 26.↵
    1. Bondi MW,
    2. Houston WS,
    3. Eyler LT,
    4. et al

    . fMRI evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease. Neurology 2005;64:501–08

    CrossRef
27. 27.↵
    1. Kukolja J,
    2. Thiel CM,
    3. Eggermann T,
    4. et al

    . Medial temporal lobe dysfunction during encoding and retrieval of episodic memory in non-demented APOE epsilon4 carriers. Neuroscience 2010;168:487–97

    CrossRefPubMed
28. 28.↵
    1. Trachtenberg AJ,
    2. Filippini N,
    3. Mackay CE

    . The effects of APOE-ε4 on the BOLD response. Neurobiol Aging 2012;33:323–34

    CrossRefPubMedWeb of Science
29. 29.↵
    1. Burggren AC,
    2. Small GW,
    3. Sabb FW,
    4. et al

    . Specificity of brain activation patterns in people at genetic risk for Alzheimer disease. Am J Geriatr Psychiatry 2002;10:44–51

    CrossRefPubMedWeb of Science
30. 30.↵
    1. Mondadori CR,
    2. de Quervain DJ,
    3. Buchmann A,
    4. et al

    . Better memory and neural efficiency in young apolipoprotein E epsilon4 carriers. Cereb Cortex 2007;17:1934–47

    Abstract/FREE Full Text
31. 31.↵
    1. Wishart HA,
    2. Saykin AJ,
    3. Rabin LA,
    4. et al

    . Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele. Am J Psychiatry 2006;163:1603–10

    CrossRefPubMedWeb of Science
32. 32.↵
    1. Galvin JE,
    2. Roe CM,
    3. Powlishta KK,
    4. et al

    . The AD8: a brief informant interview to detect dementia. Neurology 2005;65:559–64

    CrossRef
33. 33.↵
    1. Folstein MF,
    2. Folstein SE,
    3. McHugh PR

    . “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–98

    CrossRefPubMedWeb of Science
34. 34.↵
    1. Dik MG,
    2. Jonker C,
    3. Comijs HC,
    4. et al

    . Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly. Neurology 2001;57:2217–22

    CrossRef
35. 35.↵
    1. Caselli RJ,
    2. Reiman EM,
    3. Osborne D,
    4. et al

    . Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele. Neurology 2004;62:1990–95

    CrossRef
36. 36.↵
    1. Caselli RJ,
    2. Reiman EM,
    3. Locke DEC,
    4. et al

    . Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment. Arch Neurol 2007;64:1306–11

    CrossRefPubMedWeb of Science
37. 37.↵
    1. Caselli RJ,
    2. Dueck AC,
    3. Osborne D,
    4. et al

    . Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect. N Engl J Med 2009;361:255–63

    CrossRefPubMedWeb of Science
38. 38.↵
    1. Thomann PA,
    2. Roth AS,
    3. Dos Santos V,
    4. et al

    . Apolipoprotein E polymorphism and brain morphology in mild cognitive impairment. Dement Geriatr Cogn Disord 2008;26:300–05

    CrossRefPubMed
39. 39.↵
    1. Honea RA,
    2. Vidoni E,
    3. Harsha A,
    4. et al

    . Impact of APOE on the healthy aging brain: a voxel-based MRI and DTI study. J Alzheimers Dis 2009;18:553–64

    PubMedWeb of Science
40. 40.↵
    1. Spampinato MV,
    2. Rumboldt Z,
    3. Hosker RJ,
    4. et al

    . Apolipoprotein E and gray matter volume loss in patients with mild cognitive impairment and Alzheimer disease. Radiology 2011;258:843–52

    CrossRefPubMed
41. 41.↵
    1. Lu PH,
    2. Thompson PM,
    3. Leow A,
    4. et al

    . Apolipoprotein E genotype is associated with temporal and hippocampal atrophy rates in healthy elderly adults: a tensor-based morphometry study. J Alzheimers Dis 2011;23:433–42

    PubMed
42. 42.↵
    1. Greenwood PM,
    2. Lambert C,
    3. Sunderland T,
    4. et al

    . Effects of apolipoprotein E genotype on spatial attention, working memory, and their interaction in healthy, middle-aged adults: results from the National Institute of Mental Health's BIOCARD study. Neuropsychology 2005;19:199–211

    CrossRefPubMedWeb of Science
43. 43.↵
    1. Dickerson BC,
    2. Salat DH,
    3. Greve DN,
    4. et al

    . Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology 2005;65:404–11

    CrossRefPubMed
44. 44.↵
    1. Hämäläinen A,
    2. Pihlajamäki M,
    3. Tanila H,
    4. et al

    . Increased fMRI responses during encoding in mild cognitive impairment. Neurobiol Aging 2007;28:1889–903

    CrossRefPubMedWeb of Science
45. 45.↵
    1. Sperling RA,
    2. Dickerson BC,
    3. Pihlajamaki M,
    4. et al

    . Functional alterations in memory networks in early Alzheimer's disease. Neuromolecular Med 2010;12:27–43

    CrossRefPubMedWeb of Science
46. 46.↵
    1. Filbey FM,
    2. Chen G,
    3. Sunderland T,
    4. et al

    . Failing compensatory mechanisms during working memory in older apolipoprotein E-epsilon4 healthy adults. Brain Imaging Behav 2010;4:177–88

    CrossRefPubMed
47. 47.↵
    1. Sheline YI,
    2. Morris JC,
    3. Snyder AZ,
    4. et al

    . APOE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreased CSF Aβ42. J Neurosci 2010;30:17035–40

    Abstract/FREE Full Text
48. 48.↵
    1. Pike KE,
    2. Savage G,
    3. Villemagne VL,
    4. et al

    . Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease. Brain 2007;130(pt 11):2837–44

    Abstract/FREE Full Text
49. 49.↵
    1. Reiman EM,
    2. Chen K,
    3. Liu X,
    4. et al

    . Fibrillar amyloid-beta burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease. Proc Natl Acad Sci U S A 2009;106:6820–25

    Abstract/FREE Full Text